Mansfield, Carol http://orcid.org/0000-0002-3144-8938
Bullok, Kristin
Fuhs, Jillian Venci
Tockhorn-Heidenreich, Antje
Andrews, J. Scott
DiBenedetti, Dana
Matthews, Brandy R.
Darling, Joshua C.
Sutphin, Jessie
Hauber, Brett
Funding for this research was provided by:
Eli Lilly and Company
Article History
Accepted: 17 February 2022
First Online: 18 April 2022
Declarations
:
: The study was funded by Eli Lilly and Company.
: Carol Mansfield and Dana DiBenedetti are employees of RTI Health Solutions, which was contracted by Eli Lilly and Company to conduct the study. Kristin Bullok, Jillian Vinci Fuhs, Brandy R Matthews, and Antje Tockhorn-Heidenreich are employed by and stakeholders in Eli Lilly and Company. J. Scott Andrews was employed by Eli Lilly at the time this study was conducted and is currently an employee of Takeda Pharmaceuticals. Joshua Darling was employed at Eli Lilly and Company at the time this study was conducted and is currently an employee of Seagen Inc. Jessie Sutphin was an employee of RTI Health Solutions at the time this study was conducted and is currently an employee with Duke University. Brett Hauber was an employee of RTI Health Solutions at the time this study was conducted and is currently an Affiliate Associate Professor in the School of Pharmacy at the University of Washington and an employee of Pfizer, Inc.
: Approval for the study was obtained from the RTI International Institutional Review Board (No. 14025).
: Written informed consent was obtained from all study participants.
: Written informed consent was obtained from all study participants.
: All relevant data have been provided in the publication.
: Not applicable.